China Hospital Industry Report,2016-2020
  • Jan.2017
  • Hard Copy
  • USD $2,600
  • Pages:141
  • Single User License
    (PDF Unprintable)       
  • USD $2,400
  • Code: ZLC043
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,800
  • Hard Copy + Single User License
  • USD $2,800
      

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging have prompted the rapid development of China's hospital industry. As of October 2016, there had been a total of 28,584 hospitals in China, an increase of 7,666 compared with that in 2010. It is estimated that Chinese hospitals gained the revenue of RMB2,708 billion in 2016, soaring 163.3% over 2010.

Chinese medical insurance system has been gradually perfect and medical resources have swelled radically, laying the foundation for the healthy and orderly development of the hospital industry. As of the end of 2015, a total of 666 million Chinese people had enjoyed urban basic medical insurance and 670 million people had held new rural cooperative medical insurance, marking the full coverage of medical insurance. At the same time, the national medical and health institutions had offered 7.015 million beds, namely 5.11 beds for per thousand population. According to Circular on Accelerating the Construction of Health and Old-age Service Project, medical and health institutions should provide 6 beds for per thousand population (including inpatients) averagely by 2020.

Driven by the reform of public hospitals and other policies, China has set off a wave of social capital inrush to the medical industry and witnessed an upsurge in the number of private hospitals. By the end of October 2016, there had been 15,798 private hospitals in China, accounting for 55.3% of the total hospitals. However, the revenue of private hospitals is less than 10% of the total hospital revenue. In the forthcoming years, Chinese private hospitals will grow by leaps and bounds, with the number registering 20,262 and the revenue reporting RMB639.6 billion by 2020.

hospital_副本.png

Specialized hospitals need low investment costs but trigger high return on investment; coupled with the robust demand, they have attracted the fanatical investment of social capital. Private hospitals occupy more than 65% of Chinese specialized hospitals. In recent years, the revenue of Chinese specialized hospitals has been growing at around 20%; the current revenue exceeds RMB300 billion.

Among specialized hospitals, ophthalmic hospitals, stomatological hospitals as well as orthopedics & beauty hospitals enjoy exceedingly high profitability, with the profit margin of above 10%. For instance, Aier Eye Hospital, the nation's largest chain ophthalmic institution – boasts over 100 stores in the country and serves more than 3 million outpatients annually; in the first half of 2016, the company achieved the revenue of RMB1.92 billion, the net income of RMB280 million and the net profit margin of 14.6%.

The report highlights the following:
20120114.gifOverview of China hospital industry, including number of hospitals, revenue, medical services, competition pattern, forecast and prospect, etc.;
20120114.gifStatus quo of specialized hospitals in China, including overview, analysis on specialized hospitals of all sorts, summary and forecast;
20120114.gifOverview of Chinese medical insurance system, embracing status quo and development trend;
20120114.gifInvestment in China hospital industry, including related policies, comparison between public and private hospitals, investment of social capital, development directions and business models of foreign-funded hospitals;
20120114.gifOperation, hospital industry layout, development forecast, etc. of 15 enterprises.

1. Overview of China Hospital Industry
1.1 Definition
1.2 Classification
1.3 Industry Chain

2. Development of China Hospital Industry
2.1 Overview
2.1.1 Number of Hospitals
2.1.2 Distribution
2.2 Revenue
2.3 Medical Services
2.3.1 Patient Visits
2.3.2 Bed Utilization
2.4 Competition Pattern
2.5 Forecast and Prospect
2.5.1 Number and Revenue of Hospitals Will Grow Steadily
2.5.2 Public-private Partnership of Hospitals Becomes a General Trend
2.5.3 Number and Revenue of Private Hospitals Will See Steady Growth
2.5.4 Private Hospitals Tend to Be Professional 
2.5.5 Private Hospitals Will Forge Brands Gradually

3. Development of Specialized Hospitals in China 
3.1 Overview
3.1.1 Number of Specialized Hospitals
3.1.2 Revenue
3.2 Status Quo of Specialized Hospitals of All Kinds
3.2.1 Ophthalmic Hospital 
3.2.2 Stomatological Hospital
3.2.3 Orthopedics & Beauty Hospital
3.2.4 Obstetrics & Gynecology Hospital
3.2.5 Children’s Hospital
3.2.6 Tumor Hospital
3.3 Summary and Forecast

4 Development of Chinese Medical Insurance System
4.1 Status Quo
4.1.1 Medical Insurance System
4.1.2 Coverage of Medical Insurance System Is Close to Saturation
4.1.3 Serious Illness Insurance for Urban and Rural Residents
4.2 Development Trends
4.2.1 Urbanization Will Optimize Health Care System
4.2.2 Trans-regional Medical Insurance Settlement Will Be Promoted
4.2.3 Accumulated Balance of Medical Insurance Funds Grows Year by Year
4.2.4 Medical Resource Supply Capacity of County-level Hospitals Will Improve
4.2.5 Medical Resources Will Grow Rapidly

5. Investment in China Hospital Industry
5.1 Policies
5.2 Comparison between Public and Private Hospitals
5.2.1 Public Hospitals Play a Leading Role
5.2.2 Private Hospitals Run with High Efficiency
5.3 Investment Fields of Social Capital 
5.3.1 Specialized Medical Field
5.3.2 General Public Hospitals 
5.4 Development Orientation and Business Model of Foreign Hospitals
5.4.1 Status Quo of Foreign Hospitals in China 
5.4.2 Development Direction
5.4.3 Business Practice

6. Major Enterprises
6.1 Aier Eye Hospital Group
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Medical Services
6.1.7 Prediction
6.2 TC Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Medical Services
6.2.6 Prediction 
6.3 Mayinglong Pharm
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D
6.3.6 Medical Services
6.3.7 Prediction and Outlook
6.4 Shanghai Fosun Pharmaceutical (Group)
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment
6.4.6 Medical Services
6.4.7 Prediction and Outlook
6.5 Jinling Pharmaceutical Company Limited
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 R&D and Investment
6.5.6 Medical Services
6.5.7 Prediction and Outlook
6.6 Shinva Medical Instrument
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 R&D and Investment
6.6.6 Medical Services
6.6.7 Prediction and Outlook
6.7 Xi’an International Medical Investment Co., Ltd.
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Medical Services
6.7.5 Prediction and Outlook
6.8 Inner Mongolia Furui Medical Science 
6.8.1 Profile
6.8.2 Operation
6.8.3 Revenue Structure
6.8.4 Medical Services
6.8.5 Prediction and Outlook
6.9 Wuhan Jianmin Pharmaceutical Groups Corp.
6.9.1 Profile
6.9.2 Operation
6.9.3 Revenue Structure
6.9.4 Medical Services
6.9.5 Prediction and Outlook
6.10 Concord Medical Services Holdings Limited
6.10.1 Profile
6.10.2 Operation
6.10.3 Medical Services
6.10.4 Prediction and Outlook
6.11 Phoenix Healthcare Group
6.11.1 Profile
6.11.2 Operation
6.11.3 Medical Services
6.11.4 Prediction and Outlook
6.12 Guizhou Yibai Pharmaceutical
6.12.1 Profile
6.12.2 Operation
6.12.3 Medical Services
6.12.4 Prediction and Outlook
6.13 Kangmei Pharmaceutical
6.13.1 Profile
6.13.2 Operation
6.13.3 Medical Services
6.13.4 Prediction and Outlook
6.14 Jiangnan Mould & Plastic Technology
6.14.1 Profile
6.14.2 Operation
6.14.3 Medical Services
6.14.4 Prediction and Outlook
6.15 Beijing Meizhong Jiahe Hospital Management
6.15.1 Profile
6.15.2 Operation
6.15.3 Major Clients
6.15.4 Medical Services
6.15.5 Prediction and Outlook
Types and Introduction of Hospitals in China
Hospital Industry Chain in China
Number and YoY Growth of Hospitals in China, 2009-2016
Number of Hospitals in China by Hospital Level, 2009-2016
Percentage of Hospitals in China by Hospital Level, 2009-2016
Number of Hospitals in China by Economic Type, 2009-2016
Percentage of Hospitals in China by Economic Type, 2009-2016
Number of Hospitals in China by Type, 2009-2016
Number of Hospitals in China by Region as of Sept. 2016
Total Revenue of Hospitals in China, 2009-2016
Revenue Structure of Hospitals in China by Source, 2016
Revenue Structure of Hospitals in China by Hospital Type, 2016
Outpatient Visits to Hospitals in China, 2009-2016
Outpatient Visits to Hospitals in China by Economic Type, 2012-2016
Structure of Outpatient Visits to Hospitals in China by Economic Type, 2012-2016
Outpatient Visits to Hospitals in China by Hospital Type, 2012-2016
Structure of Outpatient Visits to Hospitals in China by Hospital Level, 2012-2016
Utilization of Hospital Beds in China, 2009-2016
Utilization of Hospital Beds in China by Hospital Level, 2009-2016
Proportion of Public Medical Institutions and Private Hospitals in China by Type, 2016
Medical Service Revenue of Major Private Hospitals in China, 2012-2016
Number and YoY Growth of Hospitals in China, 2015-2020E
Revenue and YoY Growth Rate of Hospitals in China, 2015-2020E
Revenue of Hospitals in China by Economic Type, 2015-2020E
Number of Private Hospitals and % of Total Hospitals in China, 2009-2020E
Revenue of Private Hospitals and % of Total Hospital Revenue in China, 2009-2020E
Number of Specialized Hospitals and % of Total Hospitals in China, 2009-2016
Proportion of Specialized Hospitals in China by Economic Type, 
Number of Specialized Hospitals in China by Type, 2010-2016
Revenue of Specialized Hospitals and % of Total Hospital Revenue in China, 2009-2016
Revenue of Specialized Hospitals in China by Type, 2010-2016
Profit Margin of Specialized Hospitals in China by Type, 2010-2016
Number of Ophthalmic Hospitals in China by Economic Type, 2009-2016
Total Revenue and Profit of Ophthalmic Hospitals in China, 2006-2016
Bed Utilization and Doctor Workload of Ophthalmic Hospitals in China, 2006-2016
Number of Stomatological Hospitals in China by Economic Type, 2009-2016
Total Revenue and Profit of Stomatological Hospitals in China, 2006-2016
Bed Utilization and Doctor Workload of Stomatological Hospitals in China, 2006-2016
Number and Distribution of Major Private Stomatological Medical Institutions and Their Chains in China, 2016
Number of Orthopedics & Beauty Hospitals in China by Economic Type, 2009-2016
Total Revenue and Profit of Orthopedics & Beauty Hospitals in China, 2006-2016
Number of Obstetrics &GynecologyHospitals in China by Economic Type, 2009-2016
Total Revenue and Profit of Obstetrics &Gynecology Hospitals in China, 2006-2016
Bed Utilization and Doctor Workload of Obstetrics &Gynecology Hospitals in China, 2006-2016
Number of Children's Hospitals in China by Economic Type, 2009-2016
Total Revenue and Profit of Children's Hospitals in China, 2009-2016
Bed Utilization and Doctor Workload of Children's Hospitals in China, 2009-2016
Number of Tumor Hospitals in China by Economic Type, 2009-2016
Total Revenue and Profit of Tumor Hospitals in China, 2006-2016
Bed Utilization and Doctor Workload of Tumor Hospitals in China, 2006-2016
Number of Specialized Hospitals and % of Total Hospitals in China, 2015-2020E
Revenue of Specialized Hospitals and % of Total Hospital Revenue in China, 2015-2020E
Structure of Medical Insurance System in China
Number of People Participating in China's Urban Resident Basic Medical Insurance by Type, 2009-2015
Number of People Participating in Chinas New Rural Cooperative Medical Scheme and Participation Rate, 2009-2015
Rate of Utilization in China, 2006-2016
Cumulative Balance of Medical Insurance Fund in China by Type, 2012-2015
Polices Supporting Construction of County-level Hospitals in China, 2009-2016
Number of Hospital Beds per Thousand Population in Chinese Medical and Health Institutions, 2014-2020E
Milestones of Social Capital Inrush to Medical Service Field in China, 1985-2016
Policies on Social Capital Flowing to Medical Service Field in China, 2009-2016
Policy Differences between Private and Public Hospitals in China
Principal-agent Chain of Public Hospitals in China
Revenue and Market Share of Public Hospitals in China, 2009-2016
Revenue and Market Share of Private Hospitals in China, 2009-2016
Comparison of Major Medical Service Items in China
Medical Service System Marketing Tendency in China
Existing Property Right System Reform Models of Public Hospitals in China
Cases of China’s Social Capital Contributing to Public Hospital Restructuring, 1999-2016
Partners and Major Medical Services of Some Sino-foreign Cooperative Hospitals in China
Partners and Major Services of Some Foreign-led Joint Venture Hospitals in China
Revenue and Net Income of Aier Eye Hospital, 2011-2016
Revenue and Net Income of Major Subsidiaries of Aier Eye Hospital, 2015
Revenue Breakdown of Aier Eye Hospital by Business, 2014-2016
Revenue Breakdown of Aier Eye Hospital by Region, 2014-2016
Revenue Structure of Aier Eye Hospital by Region, 2012-2016
Gross Margin of Aier Eye Hospital by Business, 2014-2016
R&D Expenditures of Aier Eye Hospital, 2012-2016
Planned Investment Projects by Non-public Stock Issuance of Aier Eye Hospital, 2016 
Acquisition Target Revenue and Net Income of Aier Eye Hospital, 2016 
Ownership Structure of Aier Health Insurance
Outpatient Visits of Aier Eye Hospital, 2013-2016
Surgical Operations of Aier Eye Hospital, 2013-2016
Revenue and Net Income of Aier Eye Hospital, 2015-2020E
Revenue and Net Income of TC Medical, 2011-2016
Revenue Breakdown of TC Medical by Business, 2012-2016
Revenue Breakdown of TC Medical by Region, 2012-2016
Revenue Structure of TC Medical by Region, 2012-2016
Gross Margin of TC Medical, 2012-2016
Gross Margin of TC Medical by Business, 2012-2016
Revenue and Net Income of Major Subsidiaries of TC Medical, 2013-2016
Projects Raised by Issuing Shares of TC Medical, 2015
Revenue and Net Income of TC Medical, 2015-2020E
Revenue and Net Income of Mayinglong Pharm, 2011-2016
Revenue Breakdown of Mayinglong Pharm by Business, 2012-2016
Revenue Structure of Mayinglong Pharm by Business, 2012-2016
Revenue Breakdown of Mayinglong Pharm by Region, 2012-2016
Revenue Structure of Mayinglong Pharm by Region, 2012-2016
Gross Margin of Mayinglong Pharm by Business, 2012-2016
R&D Expenditures of Mayinglong Pharm, 2012-2016
R&D Investment in Major Products of Mayinglong Pharm, 2015
Establishment Mode and Equity Structure of Anorectal Hospitals under Mayinglong Pharm
Revenue and Net Income of Mayinglong Pharm, 2015-2020E
Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2011-2016
Revenue Breakdown of Shanghai Fosun Pharmaceutical by Business, 2011-2016
Revenue Structure of Shanghai Fosun Pharmaceutical by Business, 2011-2016
Revenue Breakdown of Shanghai Fosun Pharmaceutical by Region, 2011-2016
Revenue Structure of Shanghai Fosun Pharmaceutical by Region, 2011-2016
Gross Margin of Shanghai Fosun Pharmaceutical by Business, 2011-2016
R&D Expenditures of Shanghai Fosun Pharmaceutical, 2012-201
Non-public Stock Issuance and Subscription Amount of Shanghai Fosun Pharmaceutical, 2015
Major Controlled Hospitals of Shanghai Fosun Pharmaceutical
Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2015-2020E
Revenue and Net Income of Jinling Pharmaceutical, 2011-2016
Revenue Breakdown of Jinling Pharmaceutical by Business, 2011-2016
Revenue Structure of Jinling Pharmaceutical by Business, 2011-2016
Gross Margin of Jinling Pharmaceutical by Business, 2011-2016
R&D Expenditures of Jinling Pharmaceutical, 2012-2016
Major Controlled Hospitals of Jinling Pharmaceutical
Revenue and Net Income of Jinling Pharmaceutical, 2015-2020E
Revenue and Net Income of Shinva Medical Instrument, 2011-2016
Revenue Breakdown of Shinva Medical Instrument by Business, 2011-2016
Revenue Structure of Shinva Medical Instrument by Business, 2011-2016
Revenue Breakdown of Shinva Medical Instrument by Region, 2011-2016
Revenue Structure of Shinva Medical Instrument by Region, 2011-2016
Gross Margin of Shinva Medical Instrument by Business, 2011-2016
R&D Expenditures of Shinva Medical Instrument, 2012-2015
Medical Service Related Subsidiaries of Shinva Medical Instrument
Revenue and Net Income of Shinva Medical Instrument, 2015-2020E
Revenue and Net Income of Xi’an International Medical Investment, 2011-2016
Revenue Breakdown of Xi’an International Medical Investment by Business, 2012-2016
Revenue Structure of Xi’an International Medical Investment by Business, 2012-2016
Objects for Non-public Stock Issuance, Their Rationed Shares, and Subscription Amount of Xi'an International Medical Investment, 2015
Revenue and Net Income of Xi’an International Medical Investment, 2015-2020E
Revenue and Net Income of Inner Mongolia Furui Medical Science, 2011-2016
Revenue Breakdown of Inner Mongolia Furui Medical Science by Business, 2011-2016
Revenue Structure of Inner Mongolia Furui Medical Science by Business, 2011-2016
Revenue and Net Income of Inner Mongolia Furui Medical Science, 2015-2020E
Revenue and Net Income of Wuhan Jianmin Pharmaceutical Group, 2011-2016
Revenue Breakdown of Wuhan Jianmin Pharmaceutical Group by Business, 2012-2016
Revenue Structure of Wuhan Jianmin Pharmaceutical Group by Business, 2012-2016
Revenue and Net Income of Wuhan Jianmin Pharmaceutical Group, 2015-2020E
Revenue and Net Income of Concord Medical Services, 2012-2016
Service Network Coverage of Concord Medical Services
Revenue and Net Income of Phoenix Healthcare Group, 2011-2016
General Hospital Service Revenue of Phoenix Healthcare Group, 2011-2016
Hospital Management Service Revenue of Phoenix Healthcare Group by Hospital, 2014-2016
Revenue and Net Income of Phoenix Healthcare Group, 2015-2020E
Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2011-2016
Medical Service Revenue of Guizhou Yibai Pharmaceutical, 2011-2016
Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2015-2020E
Revenue and Net Income of Kangmei Pharmaceutical, 2011-2016
Revenue and Net Income of Kangmei Pharmaceutical, 2015-2020E
Revenue and Net Income of Jiangnan Mould & Plastic Technology, 2011-2016
Purpose of Funds Raised through Non-public Stock Issuance Plan of Jiangnan Mould & Plastic Technology, 2014
Revenue and Net Income of Jiangnan Mould & Plastic Technology, 2015-2020E
Revenue and Net Income of Beijing Meizhong Jiahe Hospital Management, 2013-2016
Sales from Top 5 Customers of Beijing Meizhong Jiahe Hospital Management, 2013-2015
Purpose of Funds Raised through Second Stock Issuance Scheme of Beijing Meizhong Jiahe Hospital Management, 2016
Revenue and Net Income of Beijing Meizhong Jiahe Hospital Management, 2015-2020E

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

China Aged Care Industry Report, 2014-2017

According to the UN standard (the elderly people aged over 60 accounting for 10% of total population or the elderly people over age 65 occupying 7% of total population in one region), China entered th...

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统